| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > How to Communicate Post-Disaster - Appropriate Strategies for Nonprofits |
|
Advice You - How to Communicate Post-Disaster - Appropriate Strategies for Nonprofits
What is the place of communications in the wake of disaster? For a nonprofit, the answer lies in the way (if any) that organization is involved in the relief effort. Reading news of, campaigns for and other reactions to the tsunami tragedy has shaped my list of guidelines for appr According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product opriate nonprofit communications:
For organizations providing services in the tsunami relief effort: Communicate broadly and clearly about how donations are managed, where they are going and what your organization's relief effort is achieving. Examples: ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in >Catholic Relief Services responded immediately with life-saving food, medicine, clean water, emergency shelter, basic hygiene and household supplies. This was the first phase of CRS' phased response -- rapid-response relief to save lives, rehabilitation of damaged areas, lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. and development efforts to rebuild communities and livelihoods.http://www.catholicrelief.org/our_work/where_we_work/overseas/asia/tsunami/index.cfm/ Oxfam here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe merica solicits donations on its homepage, assuring prospective donors that "over 90% of emergency funds go directly to saving and rebuilding the lives of those in the affected areas." Oxfam goes further than Catholic Relief Services, linking its call for giving to six co d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ntent areas, including these moving accounts: • A Survivor's Story– From a camp for Sri Lankans, a survivor describes the tsunami and the work that Oxfam is doing to help. • A Personal Reflection – An Oxfam employee who is Sri Lankan reflects on how the disaster is affecti ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc g her family. • The First Hours– Oxfam staff in Sri Lanka describes the disaster. http://www.oxfamamerica.org/ Make it clear why your organization is well- equipped to help. Be as specific as possible. Example: Save easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi The Children, with a field office in the Aceh province of Indonesia, was positioned to provide aid in the region before others could arrive. The agency has since expanded its focus to include children in Sri Lanka. • Be thoughtful in your use of graphic photos of the disaster nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically The press is working for you by publicizing shocking photos of the disaster (not to mention the home videos floating around the Internet). And there's quite a bit of controversy among the press regarding this issue. Some journalists argue that graphic photos (such as dead child and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ren) are too much. Others assert that the seriousness of the disaster necessitate the use of photos to convey the gravity of the situation, especially to the jaded U.S. audience. For organizations collecting donations for aid efforts:
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi cific in conveying the process for distributing donations and where (and when) the money will be spent. Example: My local Jewish Community Center (JCC) distributed a flyer soliciting donations for tsunami relief. Working in conjunction with the United Jewish ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a Communities, the JCC explains that "UJC's unique partnership with local and overseas agencies enables us to help build and rebuild communities and ensures that we can provide a wide range of support to people at home and around the world." I'd like to know more specifics of how d dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod nations will be used for disaster relief and wish that they had included a web address where I could find out more. When I go to the UJC site on my own, I get a clear explanation of why it's soliciting donations (for its overseas aid agency, the American Jewish Joint Distribution cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin Committee) which is providing non-sectarian aid in the regions by struck the tsunami. The UJC site also details JDC's allocation of contributions to date. http://www.ujc.org/content_display.html?A tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ticleID=142336
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel you are doing, and why. Example: The JCC does a good job of explaining why they are getting involved in donations for relief support -- to filter donations to the UJC. For other nonprofits continuing with their fundraising and communications pitches: ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust >
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ervice recipients and the fact that their needs persist in the face of this terrible tragedy.
. As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ork to relief work when relevant -- but don't overstate. Make sure you don't overstate a connection between your organization, services or programs and the tsunami disaster.At the same time, acknowledge the tsunami. Pretending that it didn't happen is the worst mistake your organi elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip zation can make.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:7 Reasons To Be Patient And Find The Perfect Job What About A Career in Welding? Waitress at Marks & Spencer Saves Customer's Life
|